Clinical Trial Update: A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. [Phase 2]

View source ↗

Summary

Phase 2 study of ABT-751 in patients with recurrent breast cancer after taxane therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ABT-751 (ABT-751)

Snippet

Sponsor: Abbott | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED